Innate Immunity: Complement and Beyond
Innate Immunity: Complement and Beyond
批准号:
10464340
负责人:
Thale Cross Jarvis
金额:
$1.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-03-21 至 2023-02-28
关键词:
AcademiaAddressAreaAutoimmunityAwarenessBehaviorBiologyBiotechnologyBody partCOVID-19Cell DeathCell physiologyChromatin StructureClinicalCognitionCollaborationsComplementDisciplineDiseaseEducational workshopEyeFertilizationFosteringFutureGenesHealthHost DefenseHumanImmunityIndustryInfectionInflammasomeInnate Immune ResponseIntuitionKnowledgeLearningLyticMaintenanceMentorsMetabolismMethodologyNatural ImmunityNormal CellOutcomePathogen detectionRegulationResearchResearch PersonnelRoleSentinelSerumSystemSystems BiologyTherapeuticTimeToll-like receptorsTretinoinUpdateUtahWorkbehavior changecareerclinical practicecombatcomplement systememerging pathogenholistic approachhuman diseaseimprovedinterestnovelpathogenpostersprogramsreceptorsymposiumtherapeutic target
中文摘要
摘要
请求支助题为《先天免疫:补充和超越》的Keystone专题讨论会
由Claudia Kemper博士、Christoph Binder博士和冯绍博士组织。会议将在#年举行
雪鸟,犹他州,2022年4月3日至6日。
先天免疫力是宿主抵御感染和有害自我的支柱。病原体或危险
识别系统(PRR),包括Toll样受体(TLRs)、炎症体和维甲酸诱导
基因I(rig-I)样受体被广泛认为是先天性免疫反应的中枢节点,具有
是免疫力研究的主要内容。然而,补语系统通常唤起的作用要小得多
对研究的热情,尽管从进化的角度来看是最古老的PRR。然而,这种观点是
变化;虽然补体系统曾经被视为仅仅是一种溶解的病原体杀手,但现在它被认识到
作为正常细胞生理的活跃的细胞内协调者。这一点,再加上意识到一个
越来越多的人类疾病,甚至新冠肺炎,涉及补体紊乱,已经刺激了
重新激发了人们对补体生物学及其治疗靶点的兴趣。然而,我们对如何
补体发挥非规范的活动,它如何与其他PRR相交是稀少的。这个基石
专题讨论会将及时介绍最近我们对
补体/PRR诱导的免疫,特别关注基本细胞过程中新出现的角色
包括染色质结构的调节、新陈代谢、细胞死亡、细胞碎片/身体的清除以及
维持正常的中枢神经系统功能。第二个重点是探索这些新的PRR的异常功能是如何
活动有助于感染和自身免疫,但也会导致不太直观的临床情况,如
认知和行为。这一关于PRR生物学的整体和包括补充性的优势点汇集在一起
来自学术界和工业界的跨学科研究人员,致力于新思想和新思想的交叉培养
在生物医学进步方面的合作与人类疾病的防治相辅相成。
英文摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Innate Immunity: Complement and Beyond
organized by Drs. Claudia Kemper, Christoph Binder and Feng Shao. The conference will be held in
Snowbird, Utah from April 3-6, 2022.
Innate immunity is a pillar of the host’s defense against infection and noxious self. Pathogen or danger
recognition systems (PRRs) including toll-like receptors (TLRs), inflammasomes, and retinoic acid-inducible
gene I (RIG-I) like receptors are broadly recognized as central nodes of innate immune responses and have
been staples of immunity research. The complement system, however, generally evokes much less
enthusiasm in research, despite being the oldest PRR from an evolutionary perspective. Yet, this view is
changing; while the complement system was once viewed as a mere lytic pathogen-killer, it is now recognized
as an active intracellular orchestrator of normal cell physiology. This, together with the realization that an
increasing number of human diseases, even COVID-19, involve complement perturbations, has spurred a
reinvigorated interest in complement biology and its therapeutic targeting. However, our knowledge of how
complement exerts non-canonical activities and how it intersects with other PRRs is sparse. This Keystone
Symposia conference will provide a timely account of recent paradigm shifts in our understanding of
complement/PRR-instructed immunity with a specific eye on emerging roles in basic cellular processes
including regulation of chromatin structure, metabolism, cell death, clearance of cellular debris/corpses, and
maintenance of normal CNS function. A second focus is on exploring how aberrant function of these new PRR
activities contribute to infection and autoimmunity but also to less intuitive clinical conditions like changes in
cognition and behavior. This holistic and ‘complement-inclusive’ vantage-point on PRR biology brings together
interdisciplinary investigators from academia and industry for cross-fertilization of novel ideas and
collaborations towards biomedical progress in harnessing complement to combat human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioenergetics in Health and Diseases
-
批准号:10609120
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Autophagy and Neurodegeneration: Mechanisms to Therapies
-
批准号:10608666
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Adipose Tissue: Energizing Good Fat
-
批准号:10609127
-
项目类别:
-
资助金额:$2.02万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Cancer Neoantigens, Vaccines and Viruses
-
批准号:10233861
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Small Regulatory RNAs: From Bench to Bedside
-
批准号:10462420
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Engineering Multi-Cellular Living Systems
-
批准号:10462913
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Malaria: Confronting Challenges From Drug Discovery to Treatment
-
批准号:10468493
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Gut-Brain Axis
-
批准号:10467819
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
The Human Microbiome: Ecology and Evolution
-
批准号:10391370
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Modern Phenotypic Drug Discovery: From Chemical Biology to Therapeutics
-
批准号:10468419
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Progress in Vaccine Development for Infectious Diseases
-
批准号:10467880
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapies
-
批准号:10462412
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Drug Delivery to the Brain: Challenges and Progress
-
批准号:10540503
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neurocircuitry of Social Behavior
-
批准号:10540465
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Resolution of Inflammation
-
批准号:10469175
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Organoids as Tools for Fundamental Discovery and Translation
-
批准号:10469084
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Novel Approaches Against Emerging Antimicrobial Resistance
-
批准号:10391767
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Precision Genome Engineering
-
批准号:10391367
-
项目类别:
-
资助金额:$2.22万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neuronal Control of Appetite
-
批准号:10468571
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Inborn Errors In Immunity
-
批准号:10540279
-
项目类别:
-
资助金额:$1.6万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
海外基金